ROR2 and DAZAP2 |
receptor tyrosine kinase-like orphan receptor 2 |
DAZ associated protein 2 |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
|
|
|
|
|
ROR2 and WNT5A |
receptor tyrosine kinase-like orphan receptor 2 |
wingless-type MMTV integration site family, member 5A |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
- negative regulation of TCF-dependent signaling by WNT ligand antagonists
- Signaling by Wnt
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- WNT ligand biogenesis and trafficking
- beta-catenin independent WNT signaling
- WNT ligand secretion is abrogated by the PORCN inhibitor LGK974
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Ca2+ pathway
- TCF dependent signaling in response to WNT
- RNF mutants show enhanced WNT signaling and proliferation
- Asymmetric localization of PCP proteins
- WNT5A-dependent internalization of FZD4
- XAV939 inhibits tankyrase, stabilizing AXIN
- Signaling by WNT in cancer
- PCP/CE pathway
- Class B/2 (Secretin family receptors)
|
|
|
|
|
ROR2 and ZMYM4 |
receptor tyrosine kinase-like orphan receptor 2 |
zinc finger, MYM-type 4 |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
|
|
|
|
|
ROR2 and RBPMS |
receptor tyrosine kinase-like orphan receptor 2 |
RNA binding protein with multiple splicing |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
|
|
|
|
|
ROR2 and FZD5 |
receptor tyrosine kinase-like orphan receptor 2 |
frizzled class receptor 5 |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
- Signaling by Wnt
- GPCR ligand binding
- Metabolic disorders of biological oxidation enzymes
- beta-catenin independent WNT signaling
- disassembly of the destruction complex and recruitment of AXIN to the membrane
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Ca2+ pathway
- TCF dependent signaling in response to WNT
- regulation of FZD by ubiquitination
- RNF mutants show enhanced WNT signaling and proliferation
- Asymmetric localization of PCP proteins
- XAV939 inhibits tankyrase, stabilizing AXIN
- Signaling by WNT in cancer
- PCP/CE pathway
- Class B/2 (Secretin family receptors)
|
|
|
|
|
ROR2 and MAGED1 |
receptor tyrosine kinase-like orphan receptor 2 |
melanoma antigen family D, 1 |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
- Signalling by NGF
- Cell death signalling via NRAGE, NRIF and NADE
- NRAGE signals death through JNK
- Programmed Cell Death
- p75 NTR receptor-mediated signalling
- Role of DCC in regulating apoptosis
- Extrinsic Pathway
|
|
|
|
|
ROR2 and C1orf94 |
receptor tyrosine kinase-like orphan receptor 2 |
chromosome 1 open reading frame 94 |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
|
|
|
|
|
ROR2 and MAP3K7 |
receptor tyrosine kinase-like orphan receptor 2 |
mitogen-activated protein kinase kinase kinase 7 |
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Signaling by Wnt
- PCP/CE pathway
- beta-catenin independent WNT signaling
|
- Signaling by the B Cell Receptor (BCR)
- Downstream TCR signaling
- IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
- TRAF6 mediated induction of TAK1 complex
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Signaling by Wnt
- Toll Like Receptor TLR6:TLR2 Cascade
- Downstream signaling events of B Cell Receptor (BCR)
- Toll Like Receptor TLR1:TLR2 Cascade
- Activated TLR4 signalling
- FCERI mediated NF-kB activation
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 5 (TLR5) Cascade
- NOD1/2 Signaling Pathway
- MyD88 dependent cascade initiated on endosome
- MyD88:Mal cascade initiated on plasma membrane
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- Toll Like Receptor 9 (TLR9) Cascade
- activated TAK1 mediates p38 MAPK activation
- JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
- Innate Immune System
- IRAK2 mediated activation of TAK1 complex
- IRAK2 mediated activation of TAK1 complex
- MAP kinase activation in TLR cascade
- TRIF-mediated TLR3/TLR4 signaling
- Cytokine Signaling in Immune system
- MyD88-independent cascade
- beta-catenin independent WNT signaling
- Toll Like Receptor 2 (TLR2) Cascade
- Signaling by Interleukins
- TCR signaling
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Ca2+ pathway
- Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
- Activation of NF-kappaB in B cells
- Toll Like Receptor 4 (TLR4) Cascade
- Toll Like Receptor 3 (TLR3) Cascade
- Fc epsilon receptor (FCERI) signaling
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
|
|
|
|
NR4A2 and SMARCA2 |
nuclear receptor subfamily 4, group A, member 2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Chromatin modifying enzymes
- Chromatin organization
- RMTs methylate histone arginines
|
|
|
|
|
TBC1D25 and FEZ1 |
TBC1 domain family, member 25 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
|
|
|
|
|
ORC4 and TCF4 |
origin recognition complex, subunit 4 |
transcription factor 4 |
- G2/M Checkpoints
- Activation of the pre-replicative complex
- Activation of the pre-replicative complex
- Orc1 removal from chromatin
- Assembly of the pre-replicative complex
- Activation of ATR in response to replication stress
- G1/S Transition
- Assembly of the ORC complex at the origin of replication
- Removal of licensing factors from origins
- Mitotic G1-G1/S phases
- Switching of origins to a post-replicative state
- E2F mediated regulation of DNA replication
- Synthesis of DNA
- DNA Replication Pre-Initiation
- Regulation of DNA replication
- M/G1 Transition
- S Phase
- CDC6 association with the ORC:origin complex
- Cell Cycle, Mitotic
- Orc1 removal from chromatin
- E2F-enabled inhibition of pre-replication complex formation
- Cell Cycle Checkpoints
- Association of licensing factors with the pre-replicative complex
- CDT1 association with the CDC6:ORC:origin complex
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
P4HB and FEZ1 |
prolyl 4-hydroxylase, beta polypeptide |
fasciculation and elongation protein zeta 1 (zygin I) |
- Lipoprotein metabolism
- Hedgehog ligand biogenesis
- Metabolism of lipids and lipoproteins
- Collagen formation
- Chylomicron-mediated lipid transport
- Processing-defective Hh variants abrogate ligand secretion
- Detoxification of Reactive Oxygen Species
- Lipid digestion, mobilization, and transport
- Signaling by Hedgehog
- Collagen biosynthesis and modifying enzymes
|
|
|
|
|
|
PAFAH1B1 and TNIK |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) |
TRAF2 and NCK interacting kinase |
- Mitotic Prometaphase
- Organelle biogenesis and maintenance
- Separation of Sister Chromatids
- Assembly of the primary cilium
- G2/M Transition
- Mitotic Anaphase
- Regulation of PLK1 Activity at G2/M Transition
- Anchoring of the basal body to the plasma membrane
- M Phase
- Cell Cycle, Mitotic
- Loss of proteins required for interphase microtubule organization from the centrosome
- Resolution of Sister Chromatid Cohesion
- Loss of Nlp from mitotic centrosomes
- Centrosome maturation
- Mitotic G2-G2/M phases
- Mitotic Metaphase and Anaphase
- Recruitment of mitotic centrosome proteins and complexes
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
PAFAH1B1 and DISC1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) |
disrupted in schizophrenia 1 |
- Mitotic Prometaphase
- Organelle biogenesis and maintenance
- Separation of Sister Chromatids
- Assembly of the primary cilium
- G2/M Transition
- Mitotic Anaphase
- Regulation of PLK1 Activity at G2/M Transition
- Anchoring of the basal body to the plasma membrane
- M Phase
- Cell Cycle, Mitotic
- Loss of proteins required for interphase microtubule organization from the centrosome
- Resolution of Sister Chromatid Cohesion
- Loss of Nlp from mitotic centrosomes
- Centrosome maturation
- Mitotic G2-G2/M phases
- Mitotic Metaphase and Anaphase
- Recruitment of mitotic centrosome proteins and complexes
|
|
|
|
|
|
PARK2 and TCF4 |
parkin RBR E3 ubiquitin protein ligase |
transcription factor 4 |
- Antigen processing: Ubiquitination & Proteasome degradation
- Class I MHC mediated antigen processing & presentation
- Adaptive Immune System
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
PAX3 and POU3F2 |
paired box 3 |
POU class 3 homeobox 2 |
|
|
|
|
|
|
PCNT and DISC1 |
pericentrin |
disrupted in schizophrenia 1 |
- Organelle biogenesis and maintenance
- Loss of proteins required for interphase microtubule organization from the centrosome
- Loss of Nlp from mitotic centrosomes
- G2/M Transition
- Assembly of the primary cilium
- Centrosome maturation
- Regulation of PLK1 Activity at G2/M Transition
- Mitotic G2-G2/M phases
- Anchoring of the basal body to the plasma membrane
- Recruitment of mitotic centrosome proteins and complexes
- Cell Cycle, Mitotic
|
|
|
|
|
|
CDK16 and BAG6 |
cyclin-dependent kinase 16 |
BCL2-associated athanogene 6 |
|
|
|
|
|
|
PDE4B and DISC1 |
phosphodiesterase 4B, cAMP-specific |
disrupted in schizophrenia 1 |
- Signaling by GPCR
- GPCR downstream signaling
- G alpha (s) signalling events
- Opioid Signalling
- DARPP-32 events
|
|
- Adenosine monophosphate
- Caffeine
- Theophylline
- Dyphylline
- Pentoxifylline
- Enprofylline
- Ketotifen
- Iloprost
- Papaverine
- Theobromine
- Amrinone
- (R)-Mesopram
- Roflumilast
- Piclamilast
- 4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone
- 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
- Filaminast
- 8-Bromo-Adenosine-5\'-Monophosphate
- (S)-Rolipram
- 1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
- Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid
- (R)-Rolipram
- S,S-(2-Hydroxyethyl)Thiocysteine
- Ibudilast
- 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide
- 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
|
|
|
|
PDZK1 and SLC17A1 |
PDZ domain containing 1 |
solute carrier family 17 (organic anion transporter), member 1 |
|
- Organic anion transporters
- Transport of inorganic cations/anions and amino acids/oligopeptides
- SLC-mediated transmembrane transport
|
|
|
|
|